Here's the live share price of Wockhardt along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Wockhardt has gained 37.52% CAGR. Over the past year, the corresponding return has been 51.23%.
Wockhardt’s current P/E of -192.52x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Wockhardt | -1.14 | 2.99 | -14.19 | 1.24 | 51.23 | 82.38 | 37.52 |
Sun Pharmaceutical Industries | -0.03 | 4.02 | -3.00 | -5.06 | -14.95 | 19.89 | 25.48 |
Divi's Laboratories | -0.54 | -4.16 | -14.49 | 3.60 | 8.07 | 16.33 | 13.40 |
Cipla | 0.39 | -3.40 | 1.23 | 4.33 | -8.48 | 10.25 | 14.24 |
Torrent Pharmaceuticals | -0.53 | -1.95 | 4.94 | 9.49 | 3.65 | 30.54 | 19.99 |
Dr. Reddy's Laboratories | -2.10 | -0.74 | -1.87 | 8.55 | -7.35 | 12.18 | 3.88 |
Mankind Pharma | -2.58 | -3.46 | 2.88 | 1.40 | -2.98 | 19.91 | 11.51 |
Zydus Lifesciences | -2.96 | -0.75 | -0.68 | 10.94 | -7.49 | 34.18 | 19.01 |
Lupin | 0.54 | 4.40 | 0.22 | -1.86 | -9.69 | 39.75 | 13.68 |
Alkem Laboratories | -1.33 | 3.44 | 11.44 | 11.01 | -11.84 | 18.32 | 14.53 |
Abbott India | -0.98 | -7.53 | -15.45 | 1.17 | 5.84 | 16.66 | 13.34 |
Aurobindo Pharma | -0.30 | 7.07 | -5.54 | -5.61 | -24.98 | 26.89 | 5.33 |
Glenmark Pharmaceuticals | -2.62 | 3.08 | 11.74 | 30.44 | 20.22 | 70.23 | 31.83 |
Biocon | -1.05 | -1.15 | -4.42 | 2.88 | -1.36 | 6.44 | -5.15 |
Laurus Labs | -3.29 | 0.75 | 14.37 | 42.39 | 88.22 | 19.14 | 24.01 |
GlaxoSmithKline Pharmaceuticals | 0.58 | -0.02 | -16.66 | -1.01 | 0.47 | 24.76 | 11.88 |
Anthem Biosciences | -5.58 | -5.61 | 3.96 | 3.96 | 3.96 | 1.30 | 0.78 |
Cohance Lifesciences | -2.75 | -3.69 | -9.47 | -19.92 | -26.59 | 25.52 | 17.56 |
Ipca Laboratories | -2.74 | -4.03 | -4.39 | -7.23 | -10.74 | 11.99 | 4.10 |
Gland Pharma | -0.36 | 5.38 | 5.31 | 28.00 | 10.08 | -2.71 | 1.54 |
Over the last one year, Wockhardt has gained 51.23% compared to peers like Sun Pharmaceutical Industries (-14.95%), Divi's Laboratories (8.07%), Cipla (-8.48%). From a 5 year perspective, Wockhardt has outperformed peers relative to Sun Pharmaceutical Industries (25.48%) and Divi's Laboratories (13.40%).
Day | SMA | EMA |
---|---|---|
5 | 1,507.99 | 1,492.33 |
10 | 1,520.55 | 1,490.93 |
20 | 1,487.93 | 1,494.74 |
50 | 1,563.59 | 1,520.44 |
100 | 1,545.55 | 1,516.18 |
200 | 1,469.97 | 1,424.01 |
In the latest quarter, Wockhardt remained same as its previous close in promoter holding, while DII stake increased to 11.00%, FII holding rose to 7.29%, and public shareholding moved down to 32.60% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Tata Small Cap Fund | 19,29,375 | 2.41 | 275.42 |
HSBC Small Cap Fund - Regular Plan | 13,25,150 | 1.19 | 189.17 |
Tata Large & Mid Cap Fund - Regular Plan | 9,78,826 | 1.64 | 139.73 |
Tata Large & Mid Cap Fund - Regular Plan | 9,78,826 | 1.64 | 139.73 |
ICICI Prudential ELSS Tax Saver Fund | 7,45,664 | 0.74 | 106.44 |
Invesco India Smallcap Fund | 7,39,359 | 1.37 | 105.54 |
HDFC Large and Mid Cap Fund - Regular Plan | 6,24,757 | 0.34 | 89.18 |
HDFC Multi Cap Fund | 5,88,567 | 0.46 | 84.02 |
Bandhan Small Cap Fund | 5,72,354 | 0.56 | 81.7 |
Invesco India Contra Fund | 4,66,063 | 0.35 | 66.53 |
Date Time | Announcement |
---|---|
Oct 01, 2025, 2:31 PM IST | Wockhardt Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Sep 25, 2025, 9:45 PM IST | Wockhardt Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Sep 12, 2025, 11:43 PM IST | Wockhardt Ltd. - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 20 |
Aug 26, 2025, 10:00 PM IST | Wockhardt Ltd. - Announcement under Regulation 30 (LODR)-Credit Rating |
Aug 21, 2025, 6:18 AM IST | Wockhardt Ltd. - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
Wockhardt Ltd. is a Public Limited Listed company incorporated on 08/07/1999 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1999PLC120720 and registration number is 120720. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1402.00 Cr. and Equity Capital is Rs. 81.00 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Wockhardt is ₹1,457.25 as on Oct 03, 2025.
The Wockhardt is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Wockhardt is ₹23,679.17 Cr as on Oct 03, 2025.
Today’s highest and lowest price of Wockhardt are ₹1,514.45 and ₹1,451.05.
The 52-week high/low is the highest and lowest price at which Wockhardt stock has traded in the past 52-week or nearly a year. The 52-week high of Wockhardt is ₹1,870.00 and 52-week low of Wockhardt is ₹918.85 as on Oct 03, 2025.
The Wockhardt has shown returns of -2.48% over the past day, 2.99% for the past month, -14.19% over 3 months, 51.23% over 1 year, 82.38% across 3 years, and 37.52% over 5 years.
P/E ratio of and PB ratio of Wockhardt are -192.52 and 6.97 on Oct 03, 2025. While the company gives a dividend yield of 0.00 per annum.